"Precancerous Conditions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological conditions that tend eventually to become malignant.
| Descriptor ID |
D011230
|
| MeSH Number(s) |
C04.834
|
| Concept/Terms |
Precancerous Conditions- Precancerous Conditions
- Condition, Precancerous
- Conditions, Precancerous
- Precancerous Condition
Condition, Preneoplastic- Condition, Preneoplastic
- Preneoplastic Condition
- Preneoplastic Conditions
- Conditions, Preneoplastic
|
Below are MeSH descriptors whose meaning is more general than "Precancerous Conditions".
Below are MeSH descriptors whose meaning is more specific than "Precancerous Conditions".
This graph shows the total number of publications written about "Precancerous Conditions" by people in this website by year, and whether "Precancerous Conditions" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 9 | 3 | 12 |
| 1996 | 6 | 4 | 10 |
| 1997 | 8 | 4 | 12 |
| 1998 | 6 | 1 | 7 |
| 1999 | 7 | 3 | 10 |
| 2000 | 10 | 5 | 15 |
| 2001 | 8 | 5 | 13 |
| 2002 | 11 | 4 | 15 |
| 2003 | 12 | 7 | 19 |
| 2004 | 11 | 6 | 17 |
| 2005 | 11 | 7 | 18 |
| 2006 | 16 | 8 | 24 |
| 2007 | 11 | 10 | 21 |
| 2008 | 25 | 13 | 38 |
| 2009 | 21 | 7 | 28 |
| 2010 | 23 | 11 | 34 |
| 2011 | 21 | 8 | 29 |
| 2012 | 17 | 6 | 23 |
| 2013 | 22 | 3 | 25 |
| 2014 | 24 | 8 | 32 |
| 2015 | 20 | 6 | 26 |
| 2016 | 12 | 9 | 21 |
| 2017 | 14 | 6 | 20 |
| 2018 | 15 | 5 | 20 |
| 2019 | 22 | 5 | 27 |
| 2020 | 13 | 5 | 18 |
| 2021 | 11 | 2 | 13 |
| 2022 | 12 | 1 | 13 |
| 2023 | 19 | 0 | 19 |
| 2024 | 12 | 10 | 22 |
| 2025 | 1 | 1 | 2 |
Below are the most recent publications written about "Precancerous Conditions" by people in Profiles.
-
T helper 2 cell-directed immunotherapy eliminates precancerous skin lesions. J Clin Invest. 2025 Jan 02; 135(1).
-
Oncological Outcomes of Patients With Oral Potentially Malignant Disorders. JAMA Otolaryngol Head Neck Surg. 2025 Jan 01; 151(1):65-71.
-
AGA Clinical Practice Update on Screening and Surveillance in Individuals at Increased Risk for Gastric Cancer in the United States: Expert Review. Gastroenterology. 2025 Feb; 168(2):405-416.e1.
-
Precancerous Lesions of HPV-independent Vulvar Squamous Cell Carcinoma: Clinicopathologic Consideration of an Evolving Spectrum. Adv Anat Pathol. 2025 Jan 01; 32(1):4-19.
-
Defining precancer: a grand challenge for the cancer community. Nat Rev Cancer. 2024 Nov; 24(11):792-809.
-
The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines. Gut. 2024 Sep 09; 73(10):1607-1617.
-
Premalignant Progression in the Lung: Knowledge Gaps and Novel Opportunities for Interception of Non-Small Cell Lung Cancer. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2024 Sep 01; 210(5):548-571.
-
Actinic keratosis metrics. Arch Dermatol Res. 2024 Aug 20; 316(8):543.
-
Surgical protocols for oral leukoplakia and precancerous lesions across three different anatomic sites. Oral Dis. 2025 01; 31(1):89-98.
-
Evidence of Decreased Long-term Risk of Cervical Precancer after Negative Primary HPV Screens Compared with Negative Cytology Screens in a Longitudinal Cohort Study. Cancer Epidemiol Biomarkers Prev. 2024 Jul 01; 33(7):904-911.